Pharming Group N.V.
PHAR
$7.65
-$0.675-8.11%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.03% | 2.70% | 4.11% | ||
| Total Receivables | 5.17% | 22.21% | 0.69% | ||
| Inventory | 6.21% | 0.75% | 10.21% | ||
| Prepaid Expenses | -- | -- | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 8.43% | 4.73% | 4.70% | ||
|
|
|||||
| Total Current Assets | 8.43% | 4.73% | 4.70% | ||
| Net Property, Plant & Equipment | -10.71% | -4.74% | -3.50% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | 2.03% | -4.85% | -2.90% | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 11.44% | -2.30% | -6.40% | ||
| Total Assets | 6.05% | 1.55% | 1.61% | ||
|
|
|||||
| Total Accounts Payable | -74.38% | 5.47% | 11.35% | ||
| Total Accrued Expenses | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -1.41% | -2.39% | -1.67% | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | 14.56% | 4.78% | 10.08% | ||
|
|
|||||
| Total Current Liabilities | 14.56% | 4.78% | 10.08% | ||
| Long-Term Debt | 5.29% | -3.32% | 0.45% | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 2.69% | -5.16% | -2.50% | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 7.75% | -1.27% | 2.58% | ||
|
|
|||||
| Common Stock & APIC | 0.51% | 2.49% | 0.25% | ||
| Retained Earnings | 2.33% | -0.80% | -0.05% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 4.21% | 4.78% | 0.52% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | 4.21% | 4.78% | 0.52% | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 4.21% | 4.78% | 0.52% | ||
|
|
|||||
